Achieving high adolescent HPV vaccination coverage

Pediatrics

Volumn 138, Issue 5, 2016, Pages

  Farmar, Anna Lisa M ^a,b   Love Osborne, Kathryn ^a,b   Chichester, Katherine ^a   Breslin, Kristin ^a   Bronkan, Kristi ^a   Hambidge, Simon J ^a,b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b Nutrition Obesity Research Center at the University of Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID; WART VIRUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; DRUG SAFETY; ETHNICITY; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HISPANIC; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; URBAN AREA; VACCINATION; ANCESTRY GROUP; COLORADO; POVERTY; SAFETY NET HOSPITAL; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADOLESCENT; COLORADO; CONTINENTAL POPULATION GROUPS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; MALE; MENINGOCOCCAL VACCINES; PAPILLOMAVIRUS VACCINES; POVERTY; SAFETY-NET PROVIDERS; SEX FACTORS; URBAN POPULATION; VACCINATION;

EID: 84994853937     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-2653     Document Type: Article

References (20)

1. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013; 40(3): 187-193
2. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012; 61: 258-261
3. Elam-Evans LD, Yankey D, Jeyarajah J, et al.; Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63(29): 625-633
4. Alexander AB, Best C, Stupiansky N, Zimet GD. A model of health care provider decision making about HPV vaccination in adolescent males. Vaccine. 2015; 33(33): 4081-4086
5. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014; 168(1): 76-82
6. Hendry M, Lewis R, Clements A, Damery S, Wilkinson C. "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013; 31(45): 5152-5167
7. Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live? Pediatrics. 2004; 114(1): 187-195
8. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64(29): 784-792
9. Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 2013; 17(5): 879-885
10. Dorell C, Yankey D, Kennedy A, Stokley S. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010. Clin Pediatr (Phila). 2013; 52(2): 162-170
11. Monnat SM, Rhubart DC, Wallington S F. Differences in human papillomavirus vaccination among adolescent girls in metropolitan versus non-metropolitan areas: considering the moderating roles of maternal socioeconomic status and health care access. Matern Child Health J. 2016; 20(2): 315-325
12. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008; 43(3): 239-245
13. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2011; 29(5): 890-895
14. Clark SJ, Cowan AE, Filipp SL, Fisher AM, Stokley S. Parent perception of provider interactions influences HPV vaccination status of adolescent females. Clin Pediatr (Phila). 2016; 55(8): 701-706
15. Perkins RB, Clark JA, Apte G, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014; 134(3). Available at: www.pediatrics.org/cgi/content/full/134/3/e666
16. Schluterman NH, Terplan M, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011; 29(21): 3767-3772
17. Stokley S, Jeyarajah J, Yankey D, et al.; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep. 2014; 63(29): 620-624
18. Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, Zimet GD. What parents and their adolescent sons suggest for male HPV vaccine messaging. Health Psychol. 2014; 33(5): 448-456
19. Gabow PA, Mehler PS. A broad and structured approach to improving patient safety and quality: lessons from Denver Health. Health Aff (Millwood). 2011; 30(4): 612-618
20. Davidson AJ, Melinkovich P, Beaty BL, et al. Immunization registry accuracy: improvement with progressive clinical application [published correction appears in Am J Prev Med. 2003; 25(2): 178]. Am J Prev Med. 2003; 24(3): 276-280